Advancing the Detection and Monitoring of Traumatic Brain Injuries with Simoa® Technology
Publication Brief
The need for a more sensitive method of measuring NfL, a critical biomarker associated with traumatic brain injury (TBI), is becoming increasingly important as we continue to see a rise TBI's worldwide. Simoa® NfL blood test is seen by many as an ultra-sensitive, accurate, and non-invasive method to detect NfL proteins. Researchers can now push the boundary of detection well beyond the current limit, thus allowing the examination of critical proteins at ultra-low, even baseline, levels. Download our flyer to learn more and to view a sampling of peer-reviewed studies employing Simoa® technology for TBI research.